Skip to content

Clinical study on the relationships between airway microbiome and airway inflammation and immune state in patients with chronic airway diseases

Clinical study on the relationships between airway microbiome and airway inflammation and immune state in patients with chronic airway diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014319
Enrollment
Unknown
Registered
2018-01-05
Start date
2018-02-15
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic airway diseases

Interventions

10:no intervention

Sponsors

Department of Respiratory and Critical Care Medicine , West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The study includes patients in the Department of Respiratory Medicine of West China hospital who have received fiberbronchoscopy examination due to pulmonary nodules and reserved alveolar lavage fluid, lesions and non-lesion parts of the bronchial mucosa specimens, in which lung cancer, tuberculosis and other granulomatous diseases are excluded combined with pathological results, chest CT, clinical manifestations and other ancillary findings. Then, we enroll the patients who follow the criteria below: 1. Asthma group: newly diagnosed asthma patients following GINA2017 asthma diagnostic criteria; 2. COPD group: patients in stable moderate to severe COPD who meet GOLD2017 COPD diagnostic criteria; 3. asthma–COPD overlap (ACO) group: patients following GesEPOC2017 ACO diagnostic criteria; 4. Bronchiectasis group: patients in accordance with the 2010 British Thoracic Society non-cystic fibrosis bronchodilator diagnostic criteria.

Exclusion criteria

Exclusion criteria: (1) People who fail to complete auxiliary examinations related to diagnosis or arent enrolled in the study for other reasons; (2) People suffering from severe heart, liver or kidney dysfunction or combined with other serious systemic diseases such as the metabolic, immune, neurological or hematologic diseases and so on; (3) People with other acute and chronic respiratory diseases, including but not limited to pneumonia, tuberculosis, bronchiectasis, lung cancer, allergic pneumonia or interstitial lung disease; (4) People who are taking immunoregulatory drugs; (5) Pregnant and lactating women; (6) People who have taken antibiotics in the past 4 weeks; (7) People suffering from malignant tumors; (8) People suffering from cystic fibrosis; (9) People suffering from tractional bronchiectasis; (10) People suffering from intestinal diseases (except for inflammatory bowel diseases which can cause bronchiectasis).

Design outcomes

Primary

MeasureTime frame
The microbiome of airway;state;Airway inflammation;

Countries

China

Contacts

Public ContactChun-Tao Liu

West China Hospital, Sichuan University

taosen666@vip.163.com+86 18980601802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026